{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T22:17:12Z","timestamp":1786227432917,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>In myasthenia gravis (MG) patients, postoperative myasthenic crisis, and residual neuromuscular blocking agent (NMBA) can cause respiratory failure that requires mechanical ventilation. However, it remains unclear whether the use of sugammadex for NMBA reversal reduces postoperative myasthenic crisis in MG patients undergoing surgery. We analyzed the association between use of sugammadex and postoperative myasthenic crisis in patients with MG using a national inpatient database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Adult patients with MG who received thymectomy under general anesthesia were identified in the Japanese Diagnosis Procedure Combination database from July 1, 2010 to March 31, 2016. Patients who received sugammadex (sugammadex group) were compared with those who did not receive sugammadex (control group). The primary outcome was postoperative myasthenic crisis, and the secondary outcomes were postoperative pneumonia, tracheostomy, 28-day mortality, total hospitalization costs, and length of stay after surgery. Propensity scores were estimated by logistic regression based on the following variables: age; sex; body mass index (BMI); smoking index; history of cancer; Charlson comorbidity index (CCI); type of thymectomy; time from hospital admission to surgery; use of plasma exchange, immunosuppressants, corticosteroids, anticholinesterase, and oral benzodiazepine before surgery; type of hospital; and treatment year. The outcomes were compared using stabilized inverse probability of treatment weighting (IPTW) analyses to obtain good between-group balance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Of 795 patients identified, 506 patients received sugammadex and 289 patients did not. After stabilized IPTW, the sugammadex group was associated with a decrease in postoperative myasthenic crisis (22\/507 [4.3%] vs 25\/288 [8.7%]; odds ratio [OR], 0.48; 95% confidence interval [CI], 0.25\u20130.91), but not associated with a decrease in postoperative pneumonia (5\/507 [1.0%] vs 7\/288 [2.4%]; OR, 0.44; 95% CI, 0.17\u20131.14) or tracheostomy (7\/507 [1.4%] vs 10\/288 [3.5%]; OR, 0.38; 95% CI, 0.12\u20131.22) compared with the control group. The sugammadex group had significantly lower median (interquartile range) total hospitalization costs ($13,186 [$11,250\u2013$16,988] vs $14,119 [$11,713\u2013$20,207];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) and median length of stay after surgery (10 [8\u201315] vs 11 [8\u201318] days;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), compared with the control group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>In this retrospective observational study, sugammadex was associated with reductions in postoperative myasthenic crisis and total hospitalization costs in adult patients with MG who received thymectomy. Given the present findings, sugammadex should be routinely administered for MG patients undergoing thymectomy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000004239","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T08:14:48Z","timestamp":1558599288000},"page":"367-373","source":"Crossref","is-referenced-by-count":31,"title":["Effect of Sugammadex on Postoperative Myasthenic Crisis in Myasthenia Gravis Patients: Propensity Score Analysis of a Japanese Nationwide Database"],"prefix":"10.1213","volume":"130","author":[{"given":"Hideyuki","family":"Mouri","sequence":"first","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230812","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2008.03.004","article-title":"Thymoma, myasthenia gravis, and other paraneoplastic syndromes.","volume":"22","author":"Tormoehlen","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"R2-20230812","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/ACO.0000000000000272","article-title":"Anaesthesia for thymectomy in adult and juvenile myasthenic patients.","volume":"29","author":"Sungur","year":"2016","journal-title":"Curr Opin Anaesthesiol"},{"key":"R3-20230812","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/NCC:3:3:189","article-title":"Myasthenic crisis.","volume":"3","author":"Lacomis","year":"2005","journal-title":"Neurocrit Care"},{"key":"R4-20230812","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jclinane.2016.11.008","article-title":"Use of sugammadex in an octagenerian with myaesthenia gravis undergoing emergency laporotomy.","volume":"37","author":"Shah","year":"2017","journal-title":"J Clin Anesth"},{"key":"R5-20230812","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjan.2016.12.011","article-title":"Successful use of sugammadex for caesarean section in a patient with myasthenia gravis.","volume":"67","author":"Soyoral","year":"2017","journal-title":"Braz J Anesthesiol"},{"key":"R6-20230812","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/EJA.0000000000000153","article-title":"Reversal of neuromuscular blockade with sugammadex in patients with myasthenia gravis: a case series of 21 patients and review of the literature.","volume":"31","author":"de Boer","year":"2014","journal-title":"Eur J Anaesthesiol"},{"key":"R7-20230812","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/aas.12123","article-title":"Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.","volume":"57","author":"Sungur Ulke","year":"2013","journal-title":"Acta Anaesthesiol Scand"},{"key":"R8-20230812","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2147\/TCRM.S93009","article-title":"Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 cases.","volume":"11","author":"Vymazal","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"R9-20230812","first-page":"81","article-title":"Diagnosis procedure combination as an infrastructure for the clinical study.","volume":"5","author":"Matsuda","year":"2011","journal-title":"Asian Pac J Dis Manag"},{"key":"R10-20230812","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"R12-20230812","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1093\/ejcts\/ezt641","article-title":"Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis.","volume":"45","author":"Leuzzi","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/ejcts\/ezx163","article-title":"Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis.","volume":"52","author":"Xue","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"R14-20230812","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1213\/ANE.0000000000002332","article-title":"Bias, confounding, and interaction: lions and tigers, and bears, oh my!","volume":"125","author":"Vetter","year":"2017","journal-title":"Anesth Analg"},{"key":"R15-20230812","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"R16-20230812","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1524-4733.2009.00671.x","article-title":"Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals.","volume":"13","author":"Xu","year":"2010","journal-title":"Value Health"},{"key":"R17-20230812","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"R18-20230812","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1213\/ANE.0000000000002920","article-title":"Propensity score methods: theory and practice for anesthesia research.","volume":"127","author":"Schulte","year":"2018","journal-title":"Anesth Analg"},{"key":"R19-20230812","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/bja\/aex171","article-title":"Using a worldwide in-app survey to explore sugammadex usage patterns: a prospective observational study.","volume":"119","author":"O\u2019Reilly-Shah","year":"2017","journal-title":"Br J Anaesth"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"R21-20230812","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/EJA.0000000000000010","article-title":"Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal.","volume":"31","author":"Ledowski","year":"2014","journal-title":"Eur J Anaesthesiol"},{"key":"R22-20230812","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jclinane.2004.03.009","article-title":"Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.","volume":"17","author":"Kopman","year":"2005","journal-title":"J Clin Anesth"},{"key":"R23-20230812","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1213\/XAA.0000000000000590","article-title":"The role of sugammadex in symptomatic transient neonatal myasthenia gravis: a case report.","volume":"9","author":"Rubin","year":"2017","journal-title":"A A Case Rep"},{"key":"R24-20230812","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States: a National Registry Study.","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000004239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:23:26Z","timestamp":1786112606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000004239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000004239","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}